Maternité Port-Royal, Cochin hospital
Paris, IDF, 75014, France
Location status: Recruiting
NCT Number: NCT06427408
The single nucleus RNA-seq approach allows the placental transcriptome to be analyzed from nuclei, thus preserving the integrity of placental syncytium. This approach is feasible on small fragments of villi and offers for the first time the possibility to consider the characterization of gene expression within the structural unit of the human placenta during pregnancy (at the 1st trimester and childbirth)
Interested in participating?
Request Info18 year–50 year
Female
Observational
Paris, IDF, 75014, France
Location status: Recruiting
Chorionic villus biopsies are routinely performed between 11SA and 15SA at the Fetal Medicine Unit́ of the Port-Royal Maternity Hospital (CPDPN Cochin) after the patient has signed an information and consent form for the genetic analysis.
The patient will be asked to participate to the VilliRNAseq project and will sign the consent form of the study. After the cytogeneticist observation, a villi fragment will be snap-frozen in liquid nitrogen and stored at -80°C until use. Each patient sampled in the first trimester is followed until the end of the pregnancy. At delivery, cesarean section or vaginal delivery, a placental sample will be snap-frozen in liquid nitrogen and stored at -80°C until use.
Isolation, sorting and encapsidation of nuclei, RNA libraries preparation and sequencing will be carried out using 10x Genomics technology. State-of-the-art computational analyses to decipher trajectories and cell-to-cell communications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placental transcriptomic analysis
Time frame: Day 0
Sequencing data will be analysed at the Institut Cochin, cell trajectories will be modelled and intracellular communications will be inferred
Time frame: At childbirth
Sequencing data will be analysed at the Institut Cochin, cell trajectories will be modelled and intracellular communications will be inferred
Time frame: Day 0
Time frame: At childbirth
Time frame: Until at Childbirth
Pre-eclampsia, growth retardation in utero, delivery before 37 SA
Contact information is provided by the study sponsor or research team.
Marie BENHAMMANI-GODARD
CONTACT
Vassilis TSATSARIS, MD PHD
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Cellular Transcriptomic Trajectory of the Human Placenta During Pregnancy
Acronym: VilliRNAseq
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05434195
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Oxford, Oxfordhsire, United Kingdom
View Trial DetailsNCT06859177
Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Veldhoven, North Brabant, Netherlands
View Trial DetailsNCT06640842
Alzheimer Disease, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT06417411
Anemia, Anemia, Hemolytic
Luanda, Luanda Province, Angola
View Trial Details